Collaborating on clinical trials and research
Working with healthcare professionals (HCPs) is an essential part or our efforts to develop new medicines and vaccines. These relationships help us understand both patient needs and the benefit and risks of our products.
Doctors and other HCPs help us by identifying potential volunteers for clinical trials, administer the investigational medicine or vaccine to the patients, and monitor the results. In this way their unique medical insight and knowledge is vital to the development of new treatments.
At the core of these relationships is a shared concern for improving the health of patients, based on our values of transparency, respect, integrity and patient focus.
HCPs who work with us on clinical trials have contracts with us and are paid for their work on these clinical trials. This payment covers their time, plus the cost of investigations they may need to carry out regarding the suitability of a patient and the effectiveness of the treatment.
We have strict policies governing all our work with HCPs. These state that:
- all clinical trial investigators are selected solely on their qualifications to conduct good quality clinical research
- their history of using or not using GSK products must not be taken into account when deciding whether to include them as clinical trial investigators
- no payments are offered or made to influence their judgement on whether to enrol or maintain a patient in a clinical study
- gifts are not permissible to healthcare professionals involved in research projects for GSK
- all payments to HCPs must be governed by contracts
- any payment must reflect fair market value for the work performed and the services provided.
We also have a commitment to publically disclose the research payments that are made to healthcare professionals and to their institutions for conducting clinical research.